Phathom Pharmaceuticals Ownership | Who Owns Phathom Pharmaceuticals?
Phathom Pharmaceuticals Ownership Summary
Phathom Pharmaceuticals is owned by 88.96% institutional investors, 4.19% insiders, and 6.84% retail investors. Frazier life sciences management is the largest institutional shareholder, holding 17.32% of PHAT shares. Invesco OFI Global Equity is the top mutual fund, with 2.83% of its assets in Phathom Pharmaceuticals shares.
PHAT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Phathom Pharmaceuticals | 88.96% | 4.19% | 6.84% |
| Sector | Healthcare Stocks | 279.42% | 10.64% | -190.05% |
| Industry | Biotech Stocks | 64.05% | 10.69% | 25.27% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Frazier life sciences management | 10.11M | 17.32% | $104.13M |
| Medicxi ventures management (jersey) | 7.46M | 11.55% | $60.61M |
| Invesco | 3.67M | 5.68% | $29.81M |
| Blackrock funding, inc. /de | 3.50M | 5.42% | $28.44M |
| Carlyle group | 3.50M | 5.41% | $28.39M |
| Blackrock | 2.93M | 5.01% | $30.14M |
| Vanguard group | 2.78M | 4.30% | $22.57M |
| Ensign peak advisors | 2.53M | 3.91% | $20.52M |
| Nea management company | 1.96M | 3.03% | $15.92M |
| Gilder gagnon howe | 1.47M | 2.52% | $15.16M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Medicxi ventures management (jersey) | 7.46M | 11.46% | $60.61M |
| Catalys pacific | 1.17M | 8.18% | $9.48M |
| Propel bio management | 989.93K | 7.98% | $8.04M |
| Frazier life sciences management | 10.11M | 4.87% | $104.13M |
| Stepstone group lp | 422.08K | 3.00% | $3.43M |
| Ghost tree capital | 600.00K | 1.94% | $6.18M |
| Avidity partners management lp | 1.39M | 1.11% | $11.29M |
| Penn mutual asset management | 62.80K | 0.92% | $509.95K |
| Nea management company | 1.96M | 0.90% | $15.92M |
| Carlyle group | 3.50M | 0.68% | $28.39M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Wasatch advisors lp | 1.56M | 0.06% | 1.31M |
| Morgan stanley | 762.60K | 0.00% | 525.44K |
| Tang capital management | 500.00K | 0.27% | 500.00K |
| Gilder gagnon howe | 1.47M | 0.19% | 454.64K |
| Ubs group | 465.62K | 0.00% | 393.68K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Jennison associates | - | - | -7.04M |
| Checkpoint capital | - | - | -2.27M |
| Portolan capital management | - | - | -1.70M |
| Woodline partners lp | 1.00M | 0.06% | -1.57M |
| Orbimed advisors | - | - | -1.45M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Tang capital management | 500.00K | 0.27% | 500.00K | $4.06M |
| Trexquant investment lp | 378.64K | 0.04% | 378.64K | $3.07M |
| Bnp paribas arbitrage, snc | 39.53K | 0.00% | 39.53K | $321.00K |
| Engineers gate manager lp | 32.50K | 0.00% | 32.50K | $263.90K |
| Nebula research & development | 20.96K | 0.02% | 20.96K | $170.22K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -7.00 |
| Srs capital advisors | -17.00 |
| Capital performance advisors llp | -29.00 |
| Cwm | -32.00 |
| Rothschild investment | -35.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 142 | -4.05% | 64,025,009 | -3.98% | 88 | 0.84% | 73 | -22.34% | 35 | 34.62% |
| Dec 31, 2024 | 58 | -57.97% | 26,182,383 | -63.96% | 40 | 0.32% | 35 | -58.82% | 11 | -45.00% |
| Sep 30, 2024 | 138 | 18.97% | 72,638,512 | 28.44% | 112 | 1.21% | 85 | 28.79% | 20 | - |
| Jun 30, 2024 | 115 | -1.71% | 56,555,159 | 8.24% | 96 | 1.17% | 66 | 24.53% | 19 | -44.12% |
| Mar 31, 2024 | 117 | -2.50% | 52,249,167 | 11.99% | 91 | 1.35% | 53 | -28.38% | 34 | 47.83% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Invesco OFI Global Equity | 1.98M | 2.83% | - |
| Invesco Global A | 1.98M | 2.83% | - |
| Jennison Health Sciences Equity | 1.78M | 2.56% | - |
| Vanguard US Total Market Shares ETF | 1.65M | 2.36% | 280.90K |
| Vanguard Total Stock Mkt Idx Inv | 1.59M | 2.28% | - |
| Jennison SMid Cap Core Equity | 1.58M | 2.27% | - |
| Strategic Advisers U.S. Total Stock{mg} | 1.48M | 2.16% | -273.72K |
| Strategic Advisers Small-Mid Cap | 1.24M | 1.82% | 278.88K |
| PGIM Jennison Small Company A | 1.21M | 1.73% | -373.30K |
| Wasatch Ultra Growth | 1.01M | 1.45% | -458.57K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jul 16, 2025 | Breedlove Robert Charles | Principal Accounting Officer | Sell | $14.15K |
| May 21, 2025 | Topper James N | - | Buy | $14.61K |
| May 13, 2025 | Topper James N | - | Buy | $3.54K |
| May 14, 2025 | Topper James N | - | Buy | $20.92K |
| May 12, 2025 | Topper James N | - | Buy | $38.30K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | 1 |
| 2025 Q2 | 8 | 1 |
| 2025 Q1 | 1 | 3 |
| 2024 Q4 | 2 | 2 |
| 2024 Q3 | - | 3 |
PHAT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools